MEDICINOVA INC financial data

Symbol
MNOV on Nasdaq
Location
La Jolla, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1325% % -23%
Debt-to-equity 6% % 16%
Return On Equity -25% % -42%
Return On Assets -23% % -40%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49,046,246 shares 0%
Common Stock, Shares, Outstanding 49,046,246 shares 0%
Entity Public Float $68,589,096 USD -37%
Common Stock, Value, Issued $49,046 USD 0%
Weighted Average Number of Shares Outstanding, Basic 49,046,246 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 49,046,246 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $123,319 USD
Research and Development Expense $7,000,000 USD 6.1%
General and Administrative Expense $5,881,769 USD 17%
Operating Income (Loss) $13,374,314 USD -12%
Net Income (Loss) Attributable to Parent $12,010,330 USD -17%
Earnings Per Share, Basic 0 USD/shares -19%
Earnings Per Share, Diluted 0 USD/shares -19%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $32,562,612 USD -23%
Accounts Receivable, after Allowance for Credit Loss, Current $0 USD
Assets, Current $32,922,521 USD -24%
Property, Plant and Equipment, Net $12,933 USD -58%
Operating Lease, Right-of-Use Asset $223,698 USD -45%
Goodwill $9,600,240 USD 0%
Other Assets, Noncurrent $18,996 USD 0%
Assets $47,578,388 USD -18%
Accounts Payable, Current $745,958 USD 5.3%
Employee-related Liabilities, Current $785,949 USD -4.7%
Contract with Customer, Liability, Current $521,899 USD
Liabilities, Current $3,337,441 USD 29%
Deferred Income Tax Liabilities, Net $201,792 USD 0%
Operating Lease, Liability, Noncurrent $74,399 USD -71%
Other Liabilities, Noncurrent $74,399 USD -71%
Liabilities $3,613,632 USD 18%
Accumulated Other Comprehensive Income (Loss), Net of Tax $126,803 USD -2.4%
Retained Earnings (Accumulated Deficit) $435,946,920 USD -2.8%
Stockholders' Equity Attributable to Parent $43,964,756 USD -20%
Liabilities and Equity $47,578,388 USD -18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,783,661 USD 2.2%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 49,046,246 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,788,272 USD 1.9%
Deferred Tax Assets, Valuation Allowance $84,399,926 USD 1.2%
Deferred Tax Assets, Gross $85,635,347 USD 1.2%
Operating Lease, Liability $255,150 USD -44%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $12,013,330 USD -17%
Lessee, Operating Lease, Liability, to be Paid $273,324 USD -46%
Property, Plant and Equipment, Gross $428,241 USD -12%
Operating Lease, Liability, Current $180,751 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $17,269 USD -92%
Lessee, Operating Lease, Liability, to be Paid, Year One $206,483 USD -8.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18,174 USD -66%
Lessee, Operating Lease, Liability, to be Paid, Year Three $0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards $71,161,394 USD 1.7%
Unrecognized Tax Benefits $2,697,076 USD 70%
Lessee, Operating Lease, Liability, to be Paid, Year Four $0 USD
Operating Lease, Payments $236,142 USD -10%
Depreciation, Depletion and Amortization $5,177 USD -3.2%
Share-based Payment Arrangement, Expense $912,525 USD 32%